Dalekovod d.d. (DLKV)
Zagreb Stock Exchange · Croatia · prices in EUR · close of 14 Oct 2026
Key indicators
| Last close | EUR 17.80 |
|---|---|
| 52-week range | 7.90 – 19.80 |
| Return, 1 month / 3 months | +15.6% / +4.7% |
| Return, 1 year / 3 years | +121.9% / +509.6% |
| Trend | Uptrend |
| RSI (14) | 68 |
| Volatility (1 year) | 43.5% |
| Worst drawdown (1 year) | -30.7% |
| Average daily value traded | 0.00M EUR |
| Dividend yield | 0.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Dalekovod d.d. is a Croatian engineering and construction company based in Zagreb. It designs and builds electricity transmission lines, substations and power distribution networks, and it also carries out infrastructure work such as roads, bridges and railway systems, along with steel structures and telecommunication facilities. Its customers are mainly utilities, grid operators and public infrastructure bodies in Croatia and in other markets where it takes on projects.
The shares are listed on the Zagreb Stock Exchange in Croatia under the code DLKV, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Dalekovod d.d. (DLKV) trades on the Zagreb Stock Exchange in Croatia. It last closed at EUR 17.80 on 14 October 2026.
Its price-based Market X-Ray is 57 out of 100 (a fair price profile), ranking 21 of 45 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 121.9% and over the last three months it rose 4.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Zagreb Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 76 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 34.8% | ||
| From 52-week high | -8.7% | ||
| Momentum | 92 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 4.7% | ||
| 6-month return | 83.9% | ||
| 12-month return, skipping the last month | 92.0% | ||
| Stability (higher is calmer) | 33 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 43.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -30.7% | ||
| Liquidity | 35 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M EUR | ||
| Zero-volume days | 100.0% | ||
| Income | 18 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.6% | ||
| Years with dividends | 1 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +2.6% |
|---|---|
| 1 month | +15.6% |
| 3 months | +4.7% |
| 6 months | +83.9% |
| 1 year | +121.9% |
| 3 years | +509.6% |
| 5 years | +48.5% |
Signals
| 50-day / 200-day average | 16.40 / 13.20 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.40 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 9 Jul 2026 | EUR 0.1100 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Zagreb Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.